Exploratory experiment designed to discover new patterns targeting N/A in human lung fibroblasts. Primary outcome: fibroblast activation markers
Human lung fibroblasts were treated with identified lysophosphatidylcholines (LysoPCs) to investigate their biological effects on fibroblast activation and function. This experiment demonstrated that LysoPCs released by injured AECIIs could activate lung fibroblasts, thus promoting the progression of pulmonary fibrosis. The study examined fibroblast proliferation, migration, and fibrotic marker expression in response to LysoPC treatment.
Cell culture treatment with purified LysoPCs, assessment of activation markers
Increased fibroblast activation and pro-fibrotic responses
Significant increase in fibroblast activation markers
No related hypotheses
No debates yet
No results recorded yet. Use POST /api/experiments/{id}/results to record a result.